Preparation and characterization on the eco-friendly corn starch based adhesive of with salient water resistance, mildew resistance.

Starch adhesive is a commonly used bonding glue that is sustainable, formaldehyde-free and biodegradable. However, there are obviously some problems related to its high viscosity, poor water and mildew resistance. Hence, exploring a starch-based adhesive with good properties that satisfies the requirements of wood processing presents the context of the current research. Thus, corn starch was used as raw material to form oxidized starch (OCS) via oxidation using sodium periodate, it was reacted with a synthesis polyurea compound that prepared from hexanediamine-urea (HU) obtained by deamination to yield a oxidized starch-hexanediamine-urea adhesive (denoted hereafter as OCSHU). The oxidation process was optimized in terms of oxidant concentration, reaction time and temperature. Furthermore, the impact of HU addition on the mechanical properties of the adhesive was explored. Results indicate adhesive exhibited outstanding shear strength, when 13 % of NaIO4 was used as an oxidant to treat starch at 55 °C for 24 h, and involved in a subsequent reaction with 40 % of HU. The dry shear strength, 24 h cold water strength, 3 h hot water strength and 3 h boiling water strength are 1.84, 1.50, 1.32, and 1.31 MPa. Meantime, OCSHU adhesive solution revealed good storage stability whereas cured resin exhibited mildew resistance. The developed adhesive is a simple and green biomass wood adhesive.

The green tide causative-species Ulva prolifera responding to exposure to oil and dispersant.

In order to study the role of oil spills in the occurrence of green tide in the Yellow Sea, the physiological characteristics and photosynthetic activities of green tide causative-species Ulva prolifera was monitored under different conditions including two oil water-accommodated fractions (WAFs) of diesel oil and crude oil, dispersed water-accommodated fractions (DWAFs) and dispersant GM-2. The results showed that, the physiological parameters of U. prolifera including the growth, pigment, carbohydrate and protein contents decreased with the increased diesel oil WAF (WAFDO) concentration, while crude oil WAF (WAFCO) showed low concentration induction and high concentration inhibition effect. In addition, with the increase of WAFs concentration, two antioxidant activities were activated. However, compared with WAFDO alone and WAFCO alone, the mixture of oil and dispersant enhanced the toxicity on the above physiological characteristics of U. prolifera. On the other hand, the photosynthetic efficiency of U. prolifera showed a similar trend. Two WAFs showed significant concentration effects on the chlorophyll-a fluorescence transients and JIP-test. The addition of dispersant further blocked the electron flow beyond QA and from plastoquinone (PQ) to PSI acceptor side, damaged the active OEC centers at the PSII donor side, suppressed the pool size and the reduction rate of PSI acceptor side, and reduced the energy transfer efficiency between PSII functional units. These results implied that the crude oil spills may induce the formation of U. prolifera green tide, and the oil dispersant GM-2 used after the oil spills is unlikely to further stimulate the scale of bloom, while the diesel oil spills is always not conducive to the outbreak of green tide of U. prolifera.

Human bronchopulmonary disposition and plasma pharmacokinetics of oral bemnifosbuvir (AT-527), an experimental guanosine nucleotide prodrug for COVID-19.

BACKGROUND: Bemnifosbuvir (AT-527) is a novel oral guanosine nucleotide antiviral drug for the treatment of persons with COVID-19. Direct assessment of drug disposition in the lungs, via bronchoalveolar lavage, is necessary to ensure antiviral drug levels at the primary site of SARS-CoV-2 infection are achieved. OBJECTIVES: This Phase 1 study in healthy subjects aimed to assess the bronchopulmonary pharmacokinetics, safety and tolerability of repeated doses of bemnifosbuvir. METHODS: A total of 24 subjects were assigned to receive bemnifosbuvir twice daily at doses of 275, 550 or 825 mg for up to 3.5 days. RESULTS: AT-511, the free base of bemnifosbuvir, was largely eliminated from the plasma within 6 h post dose in all dosing groups. Antiviral drug levels of bemnifosbuvir were consistently achieved in the lungs with bemnifosbuvir 550 mg twice daily. The mean level of the guanosine nucleoside metabolite AT-273, the surrogate of the active triphosphate metabolite of the drug, measured in the epithelial lining fluid of the lungs was 0.62 µM at 4-5 h post dose. This exceeded the target in vitro 90% effective concentration (EC90) of 0.5 µM for antiviral drug exposure against SARS-CoV-2 replication in human airway epithelial cells. Bemnifosbuvir was well tolerated across all doses tested, and most treatment-emergent adverse events reported were mild in severity and resolved. CONCLUSIONS: The favourable pharmacokinetics and safety profile of bemnifosbuvir demonstrates its potential as an oral antiviral treatment for COVID-19, with 550 mg bemnifosbuvir twice daily currently under further clinical evaluation in persons with COVID-19.

First-in-human trial evaluating safety and pharmacokinetics of AT-752, a novel nucleotide prodrug with pan-serotype activity against dengue virus.

AT-752 is a novel guanosine nucleotide prodrug inhibitor of the dengue virus (DENV) polymerase with sub-micromolar, pan-serotype antiviral activity. This phase 1, double-blind, placebo-controlled, first-in-human study evaluated the safety, tolerability, and pharmacokinetics of ascending single and multiple oral doses of AT-752 in healthy subjects. AT-752 was well tolerated when administered as a single dose up to 1,500 mg or when administered as multiple doses up to 750 mg three times daily (TID). No serious adverse events occurred, and the majority of treatment-emergent adverse events were mild in severity and resolved by the end of the study. In those receiving single ascending doses of AT-752, no pharmacokinetic sensitivity was observed in Asian subjects, and no food effect was observed. Plasma exposure of the guanosine nucleoside metabolite AT-273, the surrogate of the active triphosphate metabolite of the drug, increased with increasing dose levels of AT-752 and exhibited a long half-life of approximately 15-25 h. Administration of AT-752 750 mg TID led to a rapid increase in plasma levels of AT-273 exceeding the target in vitro 90% effective concentration (EC90) of 0.64 µM in inhibiting DENV replication, and maintained this level over the treatment period. The favorable safety and pharmacokinetic results support the evaluation of AT-752 as an antiviral for the treatment of dengue in future clinical studies.Registered at ClinicalTrials.gov (NCT04722627).

Developing high performance biodegradable film based on crosslinking of cellulose acetate and tannin using caprolactone.

The use of metal catalysts during the production process of cellulose acetate (CA) film can have an impact on the environment, due to their toxicity. Diphenyl phosphate (DPP) was used instead of toxic metal catalyst to react with cellulose acetate, tannin (T) and caprolactone (CL) for preparation of cellulose acetate-caprolactone-tannin (CA-CL-T) film. The results show that DPP can produce a cross-linked network structure composed of tannin, caprolactone and cellulose acetate. The maximum molecular weight reached 113,260 Da. The introduction of tannin and caprolactone into cellulose acetate caused the resulting CA-CL-T film acquire excellent strengthening/toughening effect, in which a tensile strength of 23 MPa and elongation at break of 18 % were attained. More importantly, the resistance of the film to UV radiation was significantly improved with the tannin addition, which was corroborated by the CA-CL-T film still exhibiting a tensile strength of 13 MPa and elongation at break around 13 % after continuous exposure to UV radiation for 9 days. On the other hand, the insertion of caprolactone provoked enhancement of the overall moisture resistance. Five days treatment of the films with Penicillium sp. induced gradual drop in quality, indicating the CA-CL-T film show response to biodegradation. In all, the effective crosslinking between the components of the developed material is responsible for the acquired set of these distinct characteristics.

Synthesis and characterization of a bio-aldehyde-based lignin adhesive with desirable water resistance.

Wood-based panels find widespread application in the furniture and construction industries. However, over 90 % of adhesives used are synthesized with formaldehyde, leading to formaldehyde emission and associated health risks. In this study, an entirely bio-based adhesive (OSL) was innovatively proposed through the condensation of multi-aldehyde derived from the oxidization of sucrose (OS) with sodium lignosulfonate (L). This approach positioned oxidized sucrose (OS) as a viable substitute for formaldehyde, ensuring safety, simplicity, and enhance water resistance upon reaction with L. The optimization of the OSL adhesive preparation process involved determining the oxidant level for high sucrose conversion to aldehyde (13 % based on sucrose), the mass ratio of OS to L (0.8), and hot-pressing temperature (200 °C). Notably, the shear strength of 3-plywood bonded with the developed adhesive (1.04 MPa) increased to 1.42 MPa after being immersed in hot water at 63 ±â€¯3 °C for 3 h. Additionally, the plywood specimens exhibited excellent performance after soaking in boiling water for 3 h, resulting in a shear strength of 1.03 MPa. Chemical analysis using Fourier-transform infrared spectroscopy (FTIR), 1H nuclear magnetic resonance (NMR), and X-ray photoelectron spectroscopy (XPS) confirmed an addition reaction between L and OS, forming a dense network structure, effectively enhanceing the water resistance of OSL adhesives. Furthermore, compared with lignin-formaldehyde resin adhesive (LF), the OSL adhesive exhibited superior wet shear strength. This study offered an innovative approach for developing lignin-based adhesives utilizing a biomass aldehyde (OS), as a promising substitute for formaldehyde in the wood industry. The findings indicated that this approach may advance lignin-based adhesives, ensuring resistance to strength deterioration under highly humid environmental conditions.

The regulation of light quality on the substance production and photosynthetic activity of Dunaliella bardawil.

To study the influence and regulation of light quality on the microalgal photosynthetic activity and production of biomass and substances, green alga Dunaliella bardawil was cultured in this study under the monochromatic red light (7R0B), blue light (0R7B), and their combinations with different ratios (xRyB, x + y = 7), as well as a control of white light (W). The results demonstrated that the only advantage for control W was its chlorophyll-a (Chl-a) and Chl-b contents. All substance production at 7R0B were much lower than at control W, except of glycerol. Compared to control W, protein production at 1R6B (259.22 mg/L) was 1.10 times greater, carbohydrate production at 0R7B (306.49 mg/L) was 1.34 times higher, lipid production at 3R4B (133.60 mg/L) was 1.36 times higher, and glycerol production at 4R3B (53.58 mg/L) was 1.13 times greater. In comparison to control W, there was the significant improvements of at least 19%, 20%, and 5%, respectively, in the values of potential maximal relative electron transport efficiency (rETRmax), light intensity with saturated rETR (IK), and actual photochemical efficiency of PSII (QYss) in treatments. The correlation analysis revealed that the content of carotenoids was closely related to non-photochemical quenching (NPQ). The test using Chl-a fluorescence transients (JIP-test) proved that red light inhibited electron transport from reduced Quinone A (QA-) to QB and resulted in a sharp increase in RC/CSm, and that the blue-dominated light enhanced electron transport from QA- to QB and from plastoquinone (PQ) to PSI receptor side. The photosynthetic parameters including Ψo, φEO, φRO, δRO, PIABS, PItotal, DFABS, and DFtotal, which were positively correlated with growth and substance production, were improved by blue-dominated light. The variations in the electron transport chain might provide the signals for metabolic regulation. The results of this study will be helpful to promote the production of Dunaliella bardawil under artificial illumination and to clarify the regulating mechanism of light quality on microalgal photosynthesis.

Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymerase.

INTRODUCTION: Chronic hepatitis C virus (HCV) persists as a public health concern worldwide. Consequently, optimizing HCV therapy remains an important objective. While current therapies are generally highly effective, advanced antiviral agents are needed to maximize cure rates with potentially shorter treatment durations in a broader patient population, particularly those patients with advanced diseases who remain difficult to treat. AREAS COVERED: This review summarizes the in vitro anti-HCV activity, preclinical pharmacological properties of bemnifosbuvir (BEM, AT-527), a novel prodrug that is metabolically converted to AT-9010, the active guanosine triphosphate analogue that potently and selectively inhibits several viral RNA polymerases, including the HCV NS5B polymerase. Results from clinical proof-of-concept and phase 2 combination studies are also discussed. EXPERT OPINION: BEM exhibits potent pan-genotype activity against HCV, and has favorable safety, and drug interaction profiles. BEM is approximately 10-fold more potent than sofosbuvir against HCV genotypes (GT) tested in vitro. When combined with a potent NS5A inhibitor, BEM is expected to be a promising once-daily oral antiviral for chronic HCV infection of all genotypes and fibrosis stages with potentially short treatment durations.

Facile preparation of high-performance plywood adhesive from gelatinized corn starch crosslinked with ammonium dihydrogen phosphate.

A flame retardant high-performance gelatinized starch (GS)-ammonium dihydrogen phosphate (ADP) wood adhesive, named GS-ADP adhesive was prepared by condensation of GS and ADP under acidic condition. The preparation process of GS-ADP adhesive is very simple by mixing and stirring GS and ADP evenly at room temperature. The results revealed that the GS-ADP adhesive has good storage stability and water resistance, and its wet shear strength is much higher than that of phenolic resin (PF) adhesive. Markedly, the cone calorimeter test results show that G-ADP adhesive has good flame retardancy, and the plywood based on GS-ADP adhesive has good flame retardancy. Meanwhile, it can be seen from dynamic mechanical analysis (DMA) and thermogravimetric analysis (TGA) that GS-ADP has excellent modulus of elasticity (MOE), high glass transition temperature (Tg) and good thermal stability. The findings suggest that GS-ADP could be a viable substitute for PF resin in structural wood fabrication.

Preparation and fire resistance modification on tannin-based non-isocyanate polyurethane (NIPU) rigid foams.

Non-isocyanate polyurethane (NIPU) as a new type of polyurethane material has become a hot research topic in the polyurethane industry due to its no utilization of toxic isocyanates during the synthesis process. And the developing on recyclable biomass materials has also much attention in the industrial sector, hence the preparation and application of bio-based NIPU has also become a very meaningful study work. So, in this paper, tannin as a biomass material was used to synthesize tannin based non-isocyanate polyurethanes (TNIPU) resin, and then successfully prepared a self-blowing TNIPU foam at room temperature by using formic acid as initiator and glutaraldehyde as cross-linking agent. The compressive strength of this foam as high as 0.8 MPa, which is an excellent compressive performance. Meanwhile it will return to the state before compression when removing the pressure. This indicating that the foam has good toughness. In addition, formic acid can react with the amino groups in TNIPU to form amide substances, and generated enough heat to initiate the foaming process. Glutaraldehyde, as a crosslinking agent, reacts with the amino group in TNIPU to form a network structure system. By scanning electron microscope (SEM) observation of the cell shapes, it can be seen that the foam cells were uniform in size and shape, and the cell pores showed open and closed cells. The limiting oxygen index (LOI) tested value of this TNIPU foam is 24.45 % without any flame retardant added, but compared to the LOI value of polyurethane foam (17 %-19 %), TNIPU foam reveal a better fire resistance. It has a wider application prospect.

Associations between personal apparent temperature exposures and asthma symptoms in children with asthma.

Ambient temperature and relative humidity can affect asthma symptoms. Apparent temperature is a measure of temperature perceived by humans that takes into account the effect of humidity. However, the potential link between personal exposures to apparent temperature and asthma symptoms has not been investigated. We conducted a panel study of 37 asthmatic children, aged 5-11 years, during an early spring season (average daily ambient temperature: 14°C, range: 7-18°C). Asthma symptoms were measured 4 times for each participant with a 2-week interval between consecutive measurements using the Childhood Asthma-Control Test (C-ACT). Average, minimum, and maximum personal apparent temperature exposures, apparent temperature exposure variability (TV), and average ambient temperature were calculated for the 12 hours, 24 hours, week, and 2 weeks prior to each visit. We found that a 10°C lower in 1-week and 2-week average & minimum personal apparent temperature exposures, TV, and average ambient temperature exposures were significantly associated with lower total C-ACT scores by up to 2.2, 1.4, 3.3, and 1.4 points, respectively, indicating worsened asthma symptoms. Our results support that personal apparent temperature exposure is potentially a stronger driver than ambient temperature exposures for the variability in asthma symptom scores. Maintaining a proper personal apparent temperature exposure could be an effective strategy for personalized asthma management.

Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY).

Aim: This phase III study assessed the efficacy/safety/antiviral activity/pharmacokinetics of bemnifosbuvir, a novel, oral nucleotide analog to treat COVID-19. Patients & methods: Outpatient adults/adolescents with mild-to-moderate COVID-19 were randomized 2:1 to bemnifosbuvir/placebo. Time to symptom alleviation/improvement (primary outcome), risk of hospitalization/death, viral load and safety were evaluated. Results: Although the study was discontinued prematurely and did not meet its primary end point, bemnifosbuvir treatment resulted in fewer hospitalizations (71% relative risk reduction), COVID-19-related medically attended hospital visits, and COVID-19-related complications compared with placebo. No reduction in viral load was observed. The proportion of patients with adverse events was similar; no deaths occurred. Conclusion: Bemnifosbuvir showed hospitalization reduction in patients with variable disease progression risk and was well tolerated. Clinical Trial Registration: NCT04889040 (ClinicalTrials.gov).

An Investigation into the Relationship between Density and Pulverization Ratio for Tannin-Furanic Foam.

Four types of classical tannin-based foam samples were prepared via different methods in the current study with an attempt to find out the impact of each one on the physico-mechanical properties. The results of performed tests showed similarity to the general trend of related research, with typical negative relation between the foam density and mechanical strength. A critical point was found for each type of foam samples, for example, for tannin-formaldehyde foams (TFF), they were in the range of 85-95 kg/m3, while for tannin-glutaraldehyde foams (TGF), mechanically-generated tannin foams (MTF) and steam-driven tannin furanic foams (STDF), they were about 52-62 kg/m3, 53-63 kg/m3, and 73-83 kg/m3, respectively. This implies a significant change for density and mechanical strength, has been dig out by intensive experimental results and analysis. In addition, a non-liner relationship between density and pulverization ratio was obtained by fitting the curves obtained by the experiment results. Finally, visualization using scanning electron microscopy (SEM) together with evaluation of the compression strength presented a deeper insight to illustrate the different factors affecting foam density and pulverization ratio.

Association between Childhood Asthma Control Test scores and lung pathophysiologic indicators in longitudinal measurements.

Background: Childhood Asthma Control Test (C-ACT) is a well-validated questionnaire for asthma controls among 4-11 years old children. This study aims to examine if longitudinal C-ACT score changes could also reflect lung pathophysiologic changes. Methods: Thirty-seven children (43% female) aged 5 to 10 years old with mild or moderate asthma were followed up for 6 weeks with bi-weekly assessments of C-ACT, airway mechanics, lung function and respiratory inflammation. Associations of longitudinal changes in C-ACT score with lung pathophysiologic indicators were evaluated using linear mixed-effects models. Results: A two-point worsening of total C-ACT score (sum of child and caregiver-reported) was associated with significant decreases in forced expiratory volume during the 1st second (FEV1) by 1.7% (P=0.04) and forced vital capacity (FVC) by 1.6% (P=0.01) and increased total airway resistance [airway resistance at 5 Hz (R5)] by 3.8% (P=0.05). A two-point worsening in child-reported score was significantly associated with 3.1% and 2.5% reductions in FEV1 and FVC, respectively, and with increases in R5 by 6.5% and large airway resistance [airway resistance at 20 Hz (R20)] by 5.5%. In contrast, a two-point worsening of caregiver-reported score was associated with none of the concurrent lung pathophysiologic measurements. Worsening of total C-ACT score was significantly associated with increased respiratory inflammation [fractional exhaled nitric oxide (FeNO)] in a subset (n=23) of children without eosinophilic airway inflammation. C-ACT scores were associated with none of the small airway measures. Conclusions: In children with mild or moderate asthma, longitudinal C-ACT score changes could reflect acute changes in large airway resistance and lung function. Measures of small airway physiology would provide valuable complementary information for asthma control. Asthma phenotype may affect whether C-ACT score could reflect respiratory inflammation.

Fabrication and Process Optimization of Chinese Fir-Derived SiC Ceramic with High-Performance Friction Properties.

In this study, a novel friction material with biomass-ceramic (SiC) dual matrixes was fabricated using Chinese fir pyrocarbon via the liquid-phase silicon infiltration and in situ growth method. SiC can be grown in situ on the surface of a carbonized wood cell wall by mixing and calcination of wood and Si powder. The samples were characterized using XRD, SEM, and SEM-EDS analysis. Meanwhile, their friction coefficients and wear rates were tested to study their frictional properties. To explore the influence of crucial factors on friction performance, response surface analysis was also conducted to optimize the preparation process. The results showed that longitudinally crossed and disordered SiC nanowhiskers were grown on the carbonized wood cell wall, which could enhance the strength of SiC. The designed biomass-ceramic material had satisfying friction coefficients and low wear rates. The response surface analysis results indicate that the optimal process could be determined (carbon to silicon ratio of 3:7, reaction temperature of 1600 °C, and 5% adhesive dosage). Biomass-ceramic materials utilizing Chinese fir pyrocarbon could display great promise to potentially replace the current iron-copper-based alloy materials used in brake systems.

A Phase 2 Randomized Trial Evaluating the Antiviral Activity and Safety of the Direct-Acting Antiviral Bemnifosbuvir in Ambulatory Patients with Mild or Moderate COVID-19 (MOONSONG Study).

Bemnifosbuvir is an oral antiviral drug with a dual mechanism of action targeting viral RNA polymerase, with in vitro activity against SARS-CoV-2. We conducted a phase 2, double-blind study evaluating the antiviral activity, safety, efficacy, and pharmacokinetics of bemnifosbuvir in ambulatory patients with mild/moderate COVID-19. Patients were randomized 1:1 to bemnifosbuvir 550 mg or placebo (cohort A) and 3:1 to bemnifosbuvir 1,100 mg or placebo (cohort B); all doses were given twice daily for 5 days. The primary endpoint was a change from baseline in the amount of nasopharyngeal SARS-CoV-2 viral RNA by reverse transcription PCR (RT-PCR). The modified intent-to-treat infected population comprised 100 patients (bemnifosbuvir 550 mg, n = 30; bemnifosbuvir 1,100 mg, n = 30; cohort A placebo, n = 30; cohort B placebo, n = 10). The primary endpoint was not met: the difference in viral RNA adjusted means at day 7 was -0.25 log10 copies/mL between bemnifosbuvir 550 mg and cohort A placebo (80% confidence interval [CI], -0.66 to 0.16; P = 0.4260), and -0.08 log10 copies/mL between bemnifosbuvir 1,100 mg and pooled placebo (80% CI, -0.48 to 0.33; P = 0.8083). Bemnifosbuvir 550 mg was well tolerated. Incidence of nausea and vomiting was higher with bemnifosbuvir 1,100 mg (10.0% and 16.7% of patients, respectively) than pooled placebo (2.5% nausea, 2.5% vomiting). In the primary analysis, bemnifosbuvir did not show meaningful antiviral activity on nasopharyngeal viral load as measured by RT-PCR compared with placebo in patients with mild/moderate COVID-19. The trial is registered at ClinicalTrials.gov under registration number NCT04709835. IMPORTANCE COVID-19 continues to be a major global public health challenge, and there remains a need for effective and convenient direct-acting antivirals that can be administered outside health care settings. Bemnifosbuvir is an oral antiviral with a dual mechanism of action and potent in vitro activity against SARS-CoV-2. In this study, we evaluated the antiviral activity, safety, efficacy, and pharmacokinetics of bemnifosbuvir in ambulatory patients with mild/moderate COVID-19. In the primary analysis, bemnifosbuvir did not show meaningful antiviral activity compared with placebo as assessed by nasopharyngeal viral loads. The negative predictive value of nasopharyngeal viral load reduction for clinical outcomes in COVID-19 is currently unclear, and further evaluation of bemnifosbuvir for COVID-19 may be warranted despite the findings observed in this study.

Dimensionally Stable Delignified Bamboo Matrix Phase-Change Composite under Ambient Temperature for Indoor Thermal Regulation.

Energy storage materials to modulate indoor microclimates are needed to improve energy efficiency and for human comfort. Of these, phase-change material (PCM) is considered a very useful material because of its excellent latent heat energy storage. For application, some synthetic porous materials for supporting PCM are usually not friendly enough for people and housing environments due to their non-degradation characteristics. Hence, to develop an eco-friendly porous material is needed in order to encapsulate PCM composites that are always expected in indoor applications. In this work, heat-treated bamboo bricks were delignified to provide a delignified bamboo (DB) matrix. A phase-change composite was then fabricated by impregnating DB with polyethylene glycol (PEG) polymer. Impregnation was carried out under wet conditions to ensure the regular arrangement of the DB structure so as to achieve dimensional stability. The final DB/PEG composite was investigated for dimensional stability, load rate, latent heat, and phase-change temperature. Results showed that the DB matrix could be easily impregnated with PEG polymer under wet conditions, and the DB/PEG composite was found to have high enthalpy and a large phase-change temperature interval. Moreover, the composite was found to be a good regulator of indoor temperature and a stable dimension with a snow-white appearance. In summary, this DB/PEG composite is an energy storage material with the potential to modulate ambient indoor temperature and reduce building energy consumption.

Facile Fabrication of High-Performance Composite Films Comprising Polyvinyl Alcohol as Matrix and Phenolic Tree Extracts.

Given that tree extracts such as tannin and lignin can be efficiently used as modifying materials, this helps to verify the global trend of energy saving and environment protection. Thus, bio-based biodegradable composite film incorporating tannin and lignin as additives, together with polyvinyl alcohol (PVOH) as a matrix (denoted TLP), was prepared. Its easy preparation process endows it with high industrial value in comparison to some bio-based films with complex preparation process such as cellulose-based films. Furthermore, imaging with scanning electron microscopy (SEM) shows that the surface of tannin- and lignin-modified polyvinyl alcohol film was smooth, free of pores or cracks. Moreover, the addition of lignin and tannin improved the tensile strength of the film, which reached 31.3 MPa as indicated by mechanical characterization. This was accounted for by using Fourier transform infrared (FTIR) and electrospray ionization mass (ESI-MS) spectroscopy, which showed that the physical blending of lignin and tannin with PVOH was accompanied by chemical interactions that gave rise to weakening of the prevailing hydrogen bonding in PVOH film. In consequence, the addition of tannin and lignin acquired the composite film good resistance against the light in the ultraviolet and visible range (UV-VL). Furthermore, the film exhibited biodegradability with a mass loss about 4.22% when contaminated with Penicillium sp. for 12 days.

Highly Branched Tannin-Tris(2-aminoethyl)amine-Urea Wood Adhesives.

Condensed tannin copolymerized with hyperbranched tris(2-aminoethyl)amine-urea formed by amine-amido deamination yields a particleboard thermosetting adhesive without any aldehydes satisfying the requirements of relevant standards for the particleboard internal bond strength. The tannin-triamine-urea cures well at 180 °C, a relatively low temperature for today's particleboard hot pressing. As aldehydes were not used, the formaldehyde emission was found to be zero, not even in traces due to the heating of wood. The effect is ascribed to the presence of many reactive sites, such as amide, amino, and phenolic groups belonging to the three reagents used. The tannin appears to function as an additional cross-linking agent, almost a nucleating agent, for the triamine-urea hyperbranched oligomers. Chemical analysis by MALDI ToF and 13C NMR has shown that the predominant cross-linking reaction is that of the substitution of the tannin phenolic hydroxyls by the amino groups of the triamine. The reaction of tannin with the still-free amide groups of urea is rather rare, but it may occur with the rarer tannin flavonoid units in which the heterocyclic ring is opened. Due to the temperature gradient between the surfaces and the board core in the particleboard during hot pressing, the type and the relative balance of covalent and ionic bonds in the resin structure may differ in the surfaces and the board core.

Asymmetric Bio-epoxidation of Unactivated Alkenes.

Optically active epoxides play important roles in pharmaceutical, agricultural and fine chemical syntheses. There are many chiral medications with pharmacodynamic activity in nature that can be synthesized by chiral epoxides. In recent years, researchers have developed a variety of biocatalysts for the asymmetric epoxidation of alkenes, which use oxygen or hydrogen peroxide as eco-friendly and low-cost oxidants, to provide better chemo-, regio- and stereoselectivity under moderate reaction conditions. In this paper, the advances, opportunities and challenges of the asymmetric epoxidation of unactive alkenes by biocatalyst are reviewed.